acetylleucyl-leucyl-norleucinal and Genetic Predisposition

acetylleucyl-leucyl-norleucinal has been researched along with Genetic Predisposition in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beaney, K; Drenos, F; Humphries, SE	1
Garcia-Gomez, J; Gendzekhadze, K; Goldstein, L; Gragert, L; Hill, BT; Maiers, M; Senitzer, D; Song, J; Wang, SS; Weisenburger, D; Zhong, C	1
Allmer, C; Ansell, SM; Asmann, YW; Canioni, D; Casasnovas, O; Cerhan, JR; Cozen, W; Delarue, R; Dogan, A; Dupuis, J; Farrell, K; Ghesquières, H; Habermann, TM; Jarrett, RF; Larrabee, BR; Link, BK; Maurer, MJ; McKay, JD; Montgomery, D; Perrot, A; Salles, G; Slager, SL; Verney, A	1

Reviews

1 review(s) available for acetylleucyl-leucyl-norleucinal and Genetic Predisposition

Article	Year
How close are we to implementing a genetic risk score for coronary heart disease? Expert review of molecular diagnostics, 2017, Volume: 17, Issue:10 Topics: Coronary Disease; Genetic Association Studies; Genetic Predisposition to Disease; Genetic Testing; Genome-Wide Association Study; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leupeptins; Medication Adherence; Polymorphism, Single Nucleotide; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Risk Factors; Sex Factors; United Kingdom	2017

Article

Year

How close are we to implementing a genetic risk score for coronary heart disease?

Expert review of molecular diagnostics, 2017, Volume: 17, Issue:10

Topics: Coronary Disease; Genetic Association Studies; Genetic Predisposition to Disease; Genetic Testing; Genome-Wide Association Study; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leupeptins; Medication Adherence; Polymorphism, Single Nucleotide; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Risk Factors; Sex Factors; United Kingdom

2017

Other Studies

2 other study(ies) available for acetylleucyl-leucyl-norleucinal and Genetic Predisposition

Article	Year
The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population. Leukemia & lymphoma, 2019, Volume: 60, Issue:12 Topics: Adult; Clinical Decision-Making; Diagnosis, Differential; Disease Management; Female; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Leupeptins; Lymphoma, Non-Hodgkin; Male; Middle Aged	2019
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts. British journal of haematology, 2018, Volume: 180, Issue:2 Topics: Chromosomes, Human, Pair 8; Genes, myc; Genetic Loci; Genetic Predisposition to Disease; Hodgkin Disease; Humans; Leupeptins; Polymorphism, Single Nucleotide; Prognosis; RNA, Long Noncoding; Survival Analysis	2018

Article

Year

The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.

Leukemia & lymphoma, 2019, Volume: 60, Issue:12

Topics: Adult; Clinical Decision-Making; Diagnosis, Differential; Disease Management; Female; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Leupeptins; Lymphoma, Non-Hodgkin; Male; Middle Aged

2019

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.

British journal of haematology, 2018, Volume: 180, Issue:2

Topics: Chromosomes, Human, Pair 8; Genes, myc; Genetic Loci; Genetic Predisposition to Disease; Hodgkin Disease; Humans; Leupeptins; Polymorphism, Single Nucleotide; Prognosis; RNA, Long Noncoding; Survival Analysis

2018